Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

Lip, 2007, Atrial fibrillation and stroke prevention, Lancet Neurol, 6, 981, 10.1016/S1474-4422(07)70264-8

Mant, 2007, Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial, Lancet, 370, 493, 10.1016/S0140-6736(07)61233-1

Sato, 2006, Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial, Stroke, 37, 447, 10.1161/01.STR.0000198839.61112.ee

Stroke Risk in Atrial Fibrillation Working Group, 2007, Independent predictors of stroke in patients with atrial fibrillation: a systematic review, Neurology, 69, 546, 10.1212/01.wnl.0000267275.68538.8d

Stroke Risk in Atrial Fibrillation Working Group, 2008, Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation, Stroke, 39, 1901, 10.1161/STROKEAHA.107.501825

Baruch, 2007, Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified?, Stroke, 38, 2459, 10.1161/STROKEAHA.106.477133

Poli, 2009, Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention, Thromb Haemost, 101, 367, 10.1160/TH08-09-0592

Lip, 2006, Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation, Stroke, 37, 2294, 10.1161/01.STR.0000236840.00467.84

Fang, 2008, Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation, J Am Coll Cardiol, 51, 810, 10.1016/j.jacc.2007.09.065

Singer, 2008, Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition), Chest, 133, 546S, 10.1378/chest.08-0678

Fuster, 2006, Eur Heart J, 27, 1979, 10.1093/eurheartj/ehl176

2006

Dagres, 2007, Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation, J Am Coll Cardiol, 49, 572, 10.1016/j.jacc.2006.10.047

Fang, 2005, Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study, Circulation, 112, 1687, 10.1161/CIRCULATIONAHA.105.553438

Lane, 2009, Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients, Thromb Haemost, 101, 802, 10.1160/TH09-02-0106

Schmitt, 2009, Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications, Eur Heart J, 30, 1038, 10.1093/eurheartj/ehn579

Conway, 2004, Comparison of outcomes of patients with symptomatic peripheral artery disease with and without atrial fibrillation (the West Birmingham Atrial Fibrillation Project), Am J Cardiol, 93, 1422, 10.1016/j.amjcard.2004.02.047

Siu, 2007, Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke, Chest, 132, 44, 10.1378/chest.06-2733

Lip, 2007, Coronary artery disease and ischemic stroke in atrial fibrillation, Chest, 132, 8, 10.1378/chest.07-0500

The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography, 1998, Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation, Ann Intern Med, 128, 639, 10.7326/0003-4819-128-8-199804150-00005

Nieuwlaat, 2008, Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation, Eur Heart J, 29, 1181, 10.1093/eurheartj/ehn139

Nieuwlaat, 2006, Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation, Eur Heart J, 27, 3018, 10.1093/eurheartj/ehl015

Hart, 1999, Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials, Stroke, 30, 1223, 10.1161/01.STR.30.6.1223

Atrial Fibrillation Investigators, 1994, Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation analysis of pooled data from five randomised clinical trials, Arch Intern Med, 154, 1449, 10.1001/archinte.1994.00420130036007

Wang, 2003, A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study, JAMA, 290, 1049, 10.1001/jama.290.8.1049

Gage, 2004, Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin, Circulation, 110, 2287, 10.1161/01.CIR.0000145172.55640.93

van Walraven, 2009, Effect of age on stroke prevention therapy in patients with atrial fibrillation. The Atrial Fibrillation Investigators, Stroke, 40, 1410, 10.1161/STROKEAHA.108.526988

Hart, 2007, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation, Ann Intern Med, 146, 857, 10.7326/0003-4819-146-12-200706190-00007

Nieuwlaat, 2007, Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation, Am Heart J, 153, 1006, 10.1016/j.ahj.2007.03.008

Stroke Prevention in Atrial Fibrillation investigators, 1993, A differential effect of aspirin in prevention of stroke on atrial fibrillation, J Stroke Cerebrovasc Dis, 3, 181

2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71

Belch, 2008, BMJ, 337, a1840, 10.1136/bmj.a1840

Ogawa, 2008, Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial, JAMA, 300, 2134, 10.1001/jama.2008.623

Connolly, 2008, Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range, Circulation, 118, 2029, 10.1161/CIRCULATIONAHA.107.750000